Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
August 10, 2023 at 11:56 AM EDT
Inversago's drugs use a different approach than most treatments in the obesity and diabetes space.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|